High doses may suppress the adrenal glands and impair their ability to make natural glucocorticoid. People with such suppression (which can be identified by testing) need increased amounts of glucocorticoid orally or by the intravenous route during periods of high physical stress since higher amounts of glucocorticoids are needed by the body to fight physical stress.
Patients receiving beclomethasone may develop easy bruising if enough beclomethasone is absorbed into the body.
GENERIC AVAILABLE: No
PREPARATIONS: Nasal Inhaler: 42 or 80 mcg per spray
STORAGE: Beclomethasone should be kept at room temperature, 15 C to 30 C (59 F to 86 F). It should be shaken well before each use.
DOSING: The usual dose for the inhalers is 1-2 sprays in each nostril twice daily (Beconase AQ) or 2 sprays in each nostril once daily (QNASL). Some patients may do well with lower doses, and some require higher doses.
DRUG INTERACTIONS: No drug interactions have been described with nasal beclomethasone.
PREGNANCY: There does not appear to be any increased risk of malformations in children born to mothers exposed to beclomethasone during pregnancy. Additionally, no dependency on the drug develops, and there are no withdrawal symptoms when the medication is stopped.
NURSING MOTHERS: It is not known if beclomethasone is secreted in breast milk. Other medications in this class are secreted into breast milk. It is not known whether the small amounts that may appear in the milk are of any consequence to the infant.
Reference: FDA Prescribing Information
Quick GuideAsthma Pictures Slideshow: An Inflammatory Disorder of the Airways
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Use the pill identifier tool on RxList.